Life SciencesBiotechnologyBiotechnology Company Reports

Genmab A/S

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $175 45 Pages MarketLine November, 2015 MTLN5797087
Lowest Prices Guaranteed
Price from $175
Length 45 Pages
Publisher MarketLine
Published Date November, 2015
SKU MTLN5797087

Genmab A/S - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Genmab A/S required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Genmab A/S in the form of a SWOT analysis
  • An in-depth view of the business model of Genmab A/S including a breakdown and examination of key business segments
  • Intelligence on Genmab A/S’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Genmab A/S, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Genmab (or 'the company') is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company's therapeutic emphasis is in the areas of cancer, infectious diseases, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 157 people as of December 31, 2013.Reasons to Purchase:

  • Gain understanding of Genmab A/S and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Genmab A/S as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Genmab A/S’s business structure, strategy and prospects


    • Company Snapshot
    Genmab A/S: Company Overview
    Genmab A/S: Overview and Key Facts
    Genmab A/S: Overview
    Genmab A/S: Key Facts
    Genmab A/S: Key Employees
    Genmab A/S: Key Employee Biographies
    Genmab A/S: Major Products and Services
    Genmab A/S: Company History
    Genmab A/S: Management Statement
    Genmab A/S: Locations and Subsidiaries
    Genmab A/S: Key Competitors
    Genmab A/S: Company Analysis
    Genmab A/S: Business Description
    Genmab A/S: SWOT Analysis
    Genmab A/S: SWOT Overview
    Genmab A/S: Strengths
    Genmab A/S: Weaknesses
    Genmab A/S: Opportunities
    Genmab A/S: Threats
    Genmab A/S: Corporate Financial Deals Activity
    Genmab A/S: Financial Deals Overview
    Genmab A/S: Targets and Partners
    Genmab A/S: Top Deals 2011 - 2015YTD*
    Genmab A/S: Capital Raising
    Genmab A/S: Partnership
    Genmab A/S: Divestments
    Genmab A/S: Private Equity and Ownership
    Genmab A/S: Recent Developments
    Genmab A/S: News and Events Summary
    Genmab A/S: Business Expansion
    Genmab A/S: Corporate Governance
    Genmab A/S: Financial Performance
    Genmab A/S: Regulatory and Legal Events
    Genmab A/S: Research & Development
    Genmab A/S: Strategy and Operations
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Genmab A/S: Key Facts
    Table 2: Genmab A/S: Key Employees
    Table 4: Genmab A/S: Key Competitors
    Table 5: Genmab A/S: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Genmab A/S: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 7: Genmab A/S: Targets and Partners
    Table 8: Genmab A/S: Top Deals 2011 - 2015YTD*
    Table 9: Genmab A/S: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Table 10: Genmab A/S: Capital Raising by Deal Type (2011 - YTD*2015)
    Table 11: Genmab A/S: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 12: Genmab A/S: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 13: Genmab A/S: Divestments Volume and Value Trend (2011 - YTD*2015)
    Table 14: Genmab A/S: Divestments by Geography (2011 - YTD*2015)
    Table 15: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Table 16: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)
    Table 17: Genmab A/S: News and Events Summary
    Table 18: Genmab A/S: Business Expansion
    Table 19: Genmab A/S: Corporate Governance
    Table 20: Genmab A/S: Financial Performance
    Table 21: Genmab A/S: Regulatory and Legal Events
    Table 22: Genmab A/S: Research & Development
    Table 23: Genmab A/S: Strategy and Operations
    List of Figures
    Figure 1: Genmab A/S: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Genmab A/S: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 3: Genmab A/S: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Figure 4: Genmab A/S: Capital Raising by Deal Type (2011 - YTD*2015)
    Figure 5: Genmab A/S: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 6: Genmab A/S: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 7: Genmab A/S: Divestments Volume and Value Trend (2011 - YTD*2015)
    Figure 8: Genmab A/S: Divestments by Geography (2011 - YTD*2015)
    Figure 9: Genmab A/S: Private Equity and Ownership Volume and Value Trend (2011 - YTD*2015)
    Figure 10: Genmab A/S: Private Equity and Ownership Volume by Deal Type (2011 - YTD*2015)

    $175
    $437.50
     
    Research assistance
    US: 800.298.5699
    Int'l: +1.240.747.3093
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks